During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...

Ajai Chari, MD, stresses the importance of making bispecific therapies more accessible at the community level to improve outcomes in multiple myeloma.

The following is a summary of “Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma ...

Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.

While we've known that a healthy diet reduces the overall chance of getting cancer, there's now evidence that one eating plan ...

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow (the soft, inner parts of certain bones where new blood cells are made). They are an important part of ...

Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...

Longtime 95.5 WSB radio host Scott Slade has announced he has been diagnosed with multiple myeloma, a type of blood cancer ...

Groundbreaking research at the Yale Cancer Center offered hope for patients diagnosed with Multiple Myeloma, a type of blood ...

Former news/talk WSB radio morning host Scott Slade told the station Thursday that he has blood cancer. He said he was diagnosed last November with multiple myeloma, a type of blood cancer that ...